Merit Medical Systems | MMSI - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
3M USD 214M 18M 2026-03
Abbott USD 68M 26M 2026-03
AngioDynamics USD 102K 2K 2025-09
Anika Therapeutics 179.39M 556.84M 2026-03
AtriCure USD 1.37M 42K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 149M 4M 2026-03
Boston Scientific USD 90M 0 2026-03
Cooper Companies USD 22.4M 2M 2025-12
Dexcom USD 4.2M 500K 2025-12
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Globus Medical USD 5.44B 5.44B 2026-03
Haemonetics USD 7.4M 190K 2025-12
ICU Medical USD 20.64M 21.39M 2025-12
Insulet USD 14.7M 5.5M 2026-03
Integra LifeSciences USD 22.46M 1.21M 2026-03
J&J USD 43M 25M 2026-03
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.53M 162K 2026-03
Olympus JPY 516M 1.83B 2026-03
Pfizer USD 671M 40M 2026-03
STAAR Surgical USD 800K 799K 2025-09
Stryker USD 46.29B 45.68B 2026-03
Surmodics USD 884K 5K 2024-09
Tandem Diabetes Care USD 1.15B 1.15B 2026-03
Teleflex USD 25.72M 2.43M 2026-03
Terumo JPY 1.53B 1.06B 2026-03
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03